Whale Bay & CO

Executive Summary

Whale Bay & CO is a Dutch private company headquartered in Amsterdam, operating at the intersection of digital health and artificial intelligence. Founded in 2020, the company leverages machine learning to develop diagnostic and therapeutic solutions, though specific product details remain undisclosed. Given its limited public footprint and lack of disclosed funding or partnerships, Whale Bay appears to be in an early development stage, likely focusing on algorithm validation and regulatory pathways in Europe. The digital health AI sector in the Netherlands is competitive, with several well-funded startups; Whale Bay's differentiation is unclear. The company's profile is minimal, with no recorded publications, FDA approvals, or clinical trials, suggesting a pre-revenue or stealth phase. Without concrete milestones, the near-term outlook is uncertain.

Upcoming Catalysts (preview)

• Q3 2026Announcement of strategic partnership with a European healthcare provider or pharmaceutical company30% success
• Q4 2026Public release of initial product or platform demonstration25% success
• Q1 2027Completion of seed or Series A funding round35% success